Kraig Biocraft Laboratories Significantly Increases Spider Silk Reeling Efficiency, Boosting Per Cocoon Yield
Kraig Biocraft Laboratories (OTCQB: KBLB) has significantly improved its spider silk production efficiency. Under the guidance of Dr. Nirmal Kumar, the company has implemented new silk cocoon reeling protocols, resulting in nearly doubled reeling efficiency compared to previous production runs. This improvement addresses one of Kraig's top three goals for increasing production.
The company recently harvested its third production cycle of proprietary BAM-1 hybrid cocoons, which have been processed using the enhanced protocols. Kraig Labs is now focusing on increasing individual cocoon size and overall production volumes. The team has also selected top-performing BAM-1 parent line cocoons for production expansion this fall.
Kraig Biocraft Laboratories (OTCQB: KBLB) ha migliorato in modo significativo l'efficienza della produzione di seta di ragno. Sotto la guida del Dr. Nirmal Kumar, l'azienda ha implementato nuovi protocolli per il riavvolgimento dei bozzoli di seta, con un risultato di quasi il raddoppio dell'efficienza di riavvolgimento rispetto ai cicli di produzione precedenti. Questo miglioramento affronta uno dei principali obiettivi di Kraig per aumentare la produzione.
L'azienda ha recentemente raccolto il suo terzo ciclo di produzione di bozzoli ibridi BAM-1 proprietari, che sono stati elaborati utilizzando i protocolli migliorati. Kraig Labs si sta ora concentrando sull'aumento delle dimensioni dei singoli bozzoli e dei volumi complessivi di produzione. Il team ha anche selezionato i bozzoli della linea parentale BAM-1 a migliore prestazione per l'espansione della produzione questo autunno.
Kraig Biocraft Laboratories (OTCQB: KBLB) ha mejorado significativamente la eficiencia de producción de seda de araña. Bajo la dirección del Dr. Nirmal Kumar, la compañía ha implementado nuevos protocolos de desenrollado de capullos de seda, resultando en una eficiencia de desenrollado casi duplicada en comparación con los ciclos de producción anteriores. Esta mejora aborda uno de los tres principales objetivos de Kraig para aumentar la producción.
La empresa recientemente cosechó su tercer ciclo de producción de capullos híbridos BAM-1 propietarios, que han sido procesados utilizando los protocolos mejorados. Kraig Labs ahora se está enfocando en aumentar el tamaño de los capullos individuales y los volúmenes de producción total. El equipo también ha seleccionado los capullos de la línea parental BAM-1 de mejor rendimiento para la expansión de la producción este otoño.
Kraig Biocraft Laboratories (OTCQB: KBLB)는 거미 실크 생산 효율성을 크게 개선했습니다. Nirmal Kumar 박사의 지도 아래, 회사는 새로운 실크 고치 풀어내기 프로토콜을 구현하여 이전 생산 운전과 비교할 때 거의 두 배에 가까운 풀어내기 효율성을 달성했습니다. 이 개선은 Kraig의 생산 증가를 위한 상위 세 가지 목표 중 하나를 해결합니다.
회사는 최근 BAM-1 하이브리드 고치의 세 번째 생산 사이클을 수확했으며, 이는 개선된 프로토콜을 사용하여 처리되었습니다. Kraig Labs는 이제 개별 고치 크기와 전체 생산량을 늘리는 데 주력하고 있습니다. 팀은 또한 이번 가을 생산 확장을 위해 최고의 성능을 보이는 BAM-1 부모 라인 고치를 선택했습니다.
Kraig Biocraft Laboratories (OTCQB: KBLB) a considérablement amélioré son efficacité de production de soie d'araignée. Sous la direction du Dr. Nirmal Kumar, l'entreprise a mis en œuvre de nouveaux protocoles de dévidage des cocons de soie, entraînant une efficacité de dévidage presque doublée par rapport aux précédents cycles de production. Cette amélioration répond à l'un des trois principaux objectifs de Kraig pour augmenter la production.
L'entreprise a récemment récolté son troisième cycle de production de cocons hybrides BAM-1 propriétaires, qui ont été traités en utilisant les protocoles améliorés. Kraig Labs se concentre désormais sur l'augmentation de la taille des cocons individuels et des volumes de production globaux. L'équipe a également sélectionné les cocons de la lignée parentale BAM-1 les plus performants pour une expansion de la production cet automne.
Kraig Biocraft Laboratories (OTCQB: KBLB) hat die Effizienz der Spinnenseidenproduktion erheblich verbessert. Unter der Leitung von Dr. Nirmal Kumar hat das Unternehmen neue Protokolle für das Abwickeln von Seidenkokons implementiert, was zu einer nahezu verdoppelten Abwicklungs-effizienz im Vergleich zu früheren Produktionsläufen geführt hat. Diese Verbesserung adressiert eines von Kraigs drei Hauptzielen zur Steigerung der Produktion.
Das Unternehmen hat kürzlich seinen dritten Produktionszyklus von eigenen BAM-1 Hybridkokons geerntet, die mithilfe der verbesserten Protokolle verarbeitet wurden. Kraig Labs konzentriert sich nun darauf, die Größe der einzelnen Kokons und die Gesamtproduktionsmengen zu erhöhen. Das Team hat auch die leistungsstärksten BAM-1-Stammkokons für die Produktions-erweiterung in diesem Herbst ausgewählt.
- Nearly doubled reeling efficiency compared to previous production runs
- Successful implementation of new silk cocoon reeling protocols
- Increased total silk yields per cocoon
- Improved reeling performance
- Selection of top-performing BAM-1 parent line cocoons for production expansion
- None.
ANN ARBOR, Mich., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today that it has further boosted spider silk production with the introduction of new silk cocoon reeling protocols resulting in higher silk yields.
Under the guidance of renowned sericulture expert, Dr. Nirmal Kumar, the Kraig Labs production team modified the processing of its finished silk cocoons, increasing total silk yields per cocoon and improving reeling performance. These mechanical changes to the processing and handling of the Company's spider silk cocoons resulted in a near doubling of reeling efficiency compared to the prior production runs.
"Increasing processing efficiency and cocoon yield was one of Kraig's top three goals for increasing production," said Company founder and CEO, Kim Thompson. "Congratulations to the production team for these dramatic improvements. We anticipated many more months of work before seeing these results. Now we can focus on increasing individual cocoon size, and overall production volumes. I believe that even further gains in possessing yield can be achieved over the next two production cycles."
Dr. Nirmal Kumar and the Kraig Labs production team harvested the third production cycle of its proprietary spider silk cocoon last week. The BAM-1 hybrid cocoons have now been processed under the direction of Dr. Nirmal Kumar and the newly implemented enhanced protocols. In addition to finished reeling spider silk, the team has collected, analyzed, and selected the top performing BAM-1 parent line cocoons for production expansion this fall. Over the next week, selective matings of these top-performing moths will be used to create the next generation of BAM-1 parental line and BAM-1 production hybrids.
"Dr. Nirmal Kumar has evolved our operations at an incredible pace, bringing nuanced details and innovative troubleshooting that has netted outsized returns at a rapid pace," said Company COO, Jon Rice. "These small details and tweaks in processing the finished cocoons have yielded huge improvements in finished silk yield. Undoubtedly, his continued guidance will play a major role in our continuing expansion of production."
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com
A photo accompany this release is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b5555a2e-18e5-4d25-8693-e55f1dde4b0d
FAQ
What improvements has Kraig Biocraft Laboratories (KBLB) made in spider silk production?
What is the BAM-1 hybrid cocoon mentioned in Kraig Biocraft Laboratories' (KBLB) press release?
What are Kraig Biocraft Laboratories' (KBLB) next steps for spider silk production?
Who is Dr. Nirmal Kumar and what is his role at Kraig Biocraft Laboratories (KBLB)?
